Exciting News! Saama Wins “AI-based Life Sciences Solution of the Year” Award in 2026 AI Breakthrough Awards
The afternoon that costs you four months. Why Metadata Reuse Breaks at Scale in Global Study Builds Meta description: Most sponsors already have a global
There’s a quiet assumption baked into most “AI for clinical programming” pitches: that the hard part is generating code. Well, it isn’t. Any model can
Modern clinical trials generate data continuously, from the moment the first patient is enrolled. Yet most data management teams are still built around workflows designed
Clinical trials generate enormous amounts of data. For decades, the industry has relied on a familiar approach to keep that data clean through rules, edit
The period immediately following Data Base Lock (DBL) is often the most stressful window in a clinical trial. While the “hard work” of data collection
According to the Tufts Center for the Study of Drug Development, the average clinical trial can take 7–10 years from discovery to approval, and delays
Clinical data review has always been one of those parts of a trial that takes more time than anyone expects. An industry report by NIH
If your company is experimenting with AI, here’s a statistic worth pausing on. Recent MIT research says “95% of AI initiatives fail to show real
The pharmaceutical industry has cracked some of its toughest challenges, from shortening trial timelines to improving patient recruitment and building sophisticated data platforms. Yet one
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.
